Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Prospective multicenter observational study to assess molecular drivers of metastatic breast cancer and disease evolution upon therapeutic pressure. The main aim is to develop and validate prognostic, predictive and pathogenic markers in clinically well-characterized population-based material of breast cancer tumors and the corresponding normal tissue.These data will be used to characterize recurrent breast cancer on a molecular level, study tumor evolution, develop biomarkers of response/resistance to targeted therapy in the metastatic setting, enroll patients on targeted treatment clinical studies and to elucidate mechanisms of resistance to therapy.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Pacjentki z zaawansowanym rakiem piersi, który potwierdzono badaniami.
  • Pacjentki powyżej 18. roku życia.
  • Ogólny stan zdrowia pacjentki pozwala na uczestnictwo w badaniu (oceniane według skali ECOG do 2).
  • Rak piersi musi być widoczny na badaniach obrazowych (np. tomografia, rezonans, PET) lub potwierdzony klinicznie.
  • Badanie obrazowe pacjentki wykonano nie wcześniej niż 6 tygodni przed włączeniem do badania.
  • Pacjentka świadomie zgadza się na udział w badaniu, podpisując formularz zgody.

✗ Disqualifies

  • Nie leczone choroby psychiczne, które mogłyby utrudnić stosowanie się do zasad badania.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 16, 2025
Sex
No restrictions

Therapies / drugs in trial

Locations (2)

Lund University Hospital

Lund, Sweden

Lund University Hospital

Lund, Sweden

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.